A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
暂无分享，去创建一个
Hong-guo Zhao | Xin Wang | M. Hou | Jie Li | Miao Xu | Hai-yan Zhang | P. Qin | Xinguang Liu | Hai Zhou | J. Peng | Xiao-yuan Dong | Cheng-shan Guo | Lei Wang | Cheng-lu Yuan | Y. Meng | F. Zhou | Zhong-guang Cui | Daqi Li | K. Bi | Chuan-sheng Zhu | X. Chu | Qing-chao Wu | Cheng‐shan Guo